Skip to content

ResMed RMD Ratios & Valuation

TTM Q3 '26TTM Q2 '26TTM Q1 '26TTM Q4 '25TTM Q3 '25
Profitability
Gross margin241.9%+10.4pp239.1%+10.6pp236.6%+11.4pp234.2%+11.4pp231.5%+9.6pp
Operating margin133.8%+12.4pp131.7%+15.9pp129.7%+20.2pp126%+19.9pp121.4%+16.7pp
Net margin109.5%+13.1pp108.2%+17.1pp106.1%+20.5pp101.9%+18.7pp96.4%+13.8pp
Returns
Return on equity102.2%+4.5pp102.8%+8.5pp102.7%+12.4pp100.9%+10.5pp97.7%+6.1pp
Return on invested capital102.6%+15.8pp100.4%+20.1pp97.3%+22.9pp92.7%+19.6pp86.8%+13.7pp
Efficiency
Asset turnover2.7×0.0×2.7×0.0×2.8×0.0×2.8×0.0×2.8×0.0×
Liquidity
Current ratio12.4×+0.1×12.8×+0.9×13.1×+1.4×13.1×+1.4×12.3×0.0×
Leverage
Debt-to-equity0.7×0.0×0.7×-0.1×0.6×-0.3×0.6×-0.5×0.7×-0.6×
Net debt / EBITDA-0.7×-1.6×-0.5×-2.1×-0.2×-2.5×0.2×-2.8×0.8×-2.8×
Per Share
Book value per share$169.91+20.1%$163.03+20.6%$155.46+19.6%$148.99+20.6%$141.45+19.3%
Valuation
Market capitalization$145.46B+11.5%$145.64B+15.0%$144.05B+21.7%$139.84B+34.1%$130.44B+20.5%
Price / earnings99.8×-11.9×103.4×-13.7×106.6×-12.0×110.9×+0.6×111.7×-6.9×
Price / sales27.3×+0.5×28×+1.3×28.3×+2.8×28.1×+5.2×26.8×+2.3×
Price / book23.4×-1.6×24.3×-1.0×25.2×+0.5×25.5×+2.7×25×+0.2×
EV / EBITDA72.6×-7.2×75.7×-7.3×78×-5.6×80.3×+2.0×79.8×-5.1×
Dividend yield3.6%0.0pp3.5%-0.2pp3.4%-0.4pp3.4%-0.8pp3.6%-0.4pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are ResMed's profit margins?
ResMed (RMD) runs a 61.6% gross margin and a 34.2% operating margin, with a 27.4% net margin.
Where do ResMed's ratios come from?
Every ratio is computed from ResMed's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.